找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Concomitant Continuous Infusion Chemotherapy and Radiation; Marvin Rotman (Professor and Chairman, Dept. of Ra Textbook 1991 Springer-Verl

[復(fù)制鏈接]
樓主: mobility
51#
發(fā)表于 2025-3-30 11:31:35 | 只看該作者
52#
發(fā)表于 2025-3-30 13:41:27 | 只看該作者
53#
發(fā)表于 2025-3-30 20:04:08 | 只看該作者
Strategies for Overcoming Challenges,ally hypoxic cells thought to exist in many human tumors. A recent study examining the patterns of failure following radiation treatment for high grade brain tumors revealed that 78% of unifocal tumors recurred within 2 cm of the enhancing edge of the tumor, as demonstrated by the CT scan (W. et al.
54#
發(fā)表于 2025-3-30 21:59:17 | 只看該作者
55#
發(fā)表于 2025-3-31 01:06:03 | 只看該作者
56#
發(fā)表于 2025-3-31 08:05:01 | 只看該作者
Textbook 1991fects resulting from the administration of commonly used drugs, such as 5-fluorouracil, cisplatinum and adriamycin, with concomitant radiation therapy. Much of the data has never before been published. The wealth of information in this volume makes it a valuable reference; at the same time it gives
57#
發(fā)表于 2025-3-31 10:09:13 | 只看該作者
Experimental Rationale for Continuous Infusion Chemotherapydemonstrated the importance of dose intensity for optimal antineoplastic effect. The administration schedule required to achieve maximal dose intensity, however, is not the same for every drug. The pharmacodynamic response to any drug is a function of concentration and duration of exposure. The simp
58#
發(fā)表于 2025-3-31 14:08:48 | 只看該作者
Combination Chemotherapy by Infusion in Hematological Malignanciesnt of hematological malignancies. For the past decade our group has been interested in the use of infusional chemotherapy in the treatment of lymphomas. The following discussion will review our experiences and those of others in this area. We will also comment on work by other investigators on the u
59#
發(fā)表于 2025-3-31 20:58:53 | 只看該作者
60#
發(fā)表于 2025-4-1 00:31:46 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 15:59
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
新民市| 连州市| 伊川县| 论坛| 社会| 定边县| 策勒县| 太原市| 洪雅县| 星座| 江门市| 丰原市| 宜城市| 敦煌市| 临沭县| 毕节市| 镇沅| 鹰潭市| 鞍山市| 永和县| 那坡县| 板桥市| 广灵县| 莒南县| 竹山县| 光山县| 武穴市| 旌德县| 石城县| 凤阳县| 桐梓县| 龙泉市| 合山市| 佳木斯市| 乃东县| 通海县| 拉孜县| 龙川县| 衡东县| 平定县| 谢通门县|